腾讯网13 天
FDA通过附加条件扩大非处方药类型
美国 FDA 于 12 月 23 日发布了一项最终规章，为具有非处方药使用附加条件（additional condition for nonprescription use，ACNU）的非处方药产品制定要求。带有 ACNU ...
Petros announces ‘conducive position’ with newly approved FDA OTC final rules
Petros Pharmaceuticals (PTPI) announces its conducive position in connection with the recently issued final rule, “Nonprescription Drug ...
Becker's Hospital Review5 天
FDA finalizes nonprescription drug rule: 5 notes
The FDA's final rule defines a nonprescription drug product with an ACNU as one that could be marketed without a prescription if the manufacturer implements an additional condition to ensure ...
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly ...
Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros ...
FDA proposes pulling Sudafed and Benadryl from pharmacy shelves
The agency proposed on Thursday discontinuing the use of phenylephrine - an ingredient in common medications like Vicks Sinex ...